GLYCOSAMINOGLYCAN FRACTIONS FROM HUMAN ARTERIES PRESENTING DIVERSE SUSCEPTIBILITIES TO ATHEROSCLEROSIS HAVE DIFFERENT BINDING AFFINITIES TO PLASMA LDL

被引:91
作者
CARDOSO, LEM
MOURAO, PAS
机构
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1994年 / 14卷 / 01期
关键词
GLYCOSAMINOGLYCANS; CHONDROITIN SULFATE; HEPARAN SULFATE; ATHEROSCLEROSIS RISK FACTORS; LDL; ARTERIAL CONNECTIVE TISSUE;
D O I
10.1161/01.ATV.14.1.115
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The topographic distribution of atherosclerotic lesions is influenced by biochemical factors intrinsic to the arterial wall. In the present work we have investigated whether the composition/chemical structure of glycosaminoglycans constitutes one of these factors. Normal human arteries were obtained at necropsy, and in order of decreasing susceptibility to atherosclerosis, consisted of the abdominal and thoracic aortas and the iliac and pulmonary arteries. The results showed similar concentrations of total glycosaminoglycan and collagen. Of the glycosaminoglycans known to interact with low-density lipoprotein (LDL), dermatan sulfate was present in all arteries in comparable concentrations, but the aortas had a 30% higher content of chondroitin 4/6-sulfate, which in turn was slightly enriched in 6-sulfated disaccharide units. LDL-affinity chromatography with dermatan sulfate+chondroitin 4/6-sulfate fractions demonstrated that increasing affinity to LDL matched an increasing susceptibility to atherosclerosis. Analysis of glycosaminoglycans in the eluates indicated a positive correlation between affinity to LDL and increasing molecular weight and the existence of a fraction of glycosaminoglycans of high affinity to LDL in the aortas only. These results suggest that arterial glycosaminoglycans participate in the multifactorial mechanisms that modulate the differential localization of atherosclerotic lesions.
引用
收藏
页码:115 / 124
页数:10
相关论文
共 51 条
  • [1] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [2] INTERACTION OF HIGH MOLECULAR-WEIGHT CHONDROITIN SULFATE FROM HUMAN AORTA WITH PLASMA LOW-DENSITY LIPOPROTEINS
    ALVES, CS
    MOURAO, PAS
    [J]. ATHEROSCLEROSIS, 1988, 73 (2-3) : 113 - 124
  • [3] BABAEV VR, 1990, AM J PATHOL, V136, P1031
  • [4] PROTEOGLYCANS AND POTENTIAL MECHANISMS RELATED TO ATHEROSCLEROSIS
    BERENSON, GS
    RADHAKRISHNAMURTHY, B
    SRINIVASAN, SR
    VIJAYAGOPAL, P
    DALFERES, ER
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 454 : 69 - 78
  • [5] 2 IMPROVED AND SIMPLIFIED METHODS FOR SPECTROPHOTOMETRIC DETERMINATION OF HYDROXYPROLINE
    BERGMAN, I
    LOXLEY, R
    [J]. ANALYTICAL CHEMISTRY, 1963, 35 (12) : 1961 - &
  • [6] MODIFICATIONS OF LOW-DENSITY-LIPOPROTEIN INDUCED BY ARTERIAL PROTEOGLYCANS AND CHONDROITIN-6-SULFATE
    CAMEJO, G
    HURT, E
    WIKLUND, O
    ROSENGREN, B
    LOPEZ, F
    BONDJERS, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1096 (03) : 253 - 261
  • [7] CAMEJO G, 1985, BIOMED BIOCHIM ACTA, V44, P389
  • [8] CARDOSO LEM, 1992, LAB INVEST, V67, P588
  • [9] A COMPETITIVE ASSAY OF LIPOPROTEIN-PROTEOGLYCAN INTERACTION USING A 96-WELL MICROTITRATION PLATE
    CHRISTNER, JE
    BAKER, JR
    [J]. ANALYTICAL BIOCHEMISTRY, 1990, 184 (02) : 388 - 394
  • [10] ELASTIN-PROTEOGLYCANS ASSOCIATION REVEALED BY CYTOCHEMICAL METHODS
    CONTRI, MB
    FORNIERI, C
    RONCHETTI, IP
    [J]. CONNECTIVE TISSUE RESEARCH, 1985, 13 (03) : 237 - 249